sphingotec GmbH
Hennigsdorf, DE · Founded 2002 · 20 employees on LinkedIn · 3 known investors
Find your way into sphingotec GmbH
Sign up to see every warm intro you have to sphingotec GmbH
- Paths you didn't know you had: your email and LinkedIn already hold routes to the sphingotec GmbH team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
SphingoTec develops proprietary biomarkers for critical care diagnostics, addressing acute kidney injury, sepsis, and acute heart failure through partnerships with in vitro diagnostics companies and pharmaceutical firms. The company licenses its biomarker portfolio to global IVD partners to make clinical diagnostic products available worldwide.
Founders & leadership
Investors · 3
Frequently asked questions
- What does sphingotec GmbH do?
- SphingoTec develops proprietary biomarkers for critical care diagnostics, addressing acute kidney injury, sepsis, and acute heart failure through partnerships with in vitro diagnostics companies and pharmaceutical firms. The company licenses its biomarker portfolio to global IVD partners to make clinical diagnostic products available worldwide.
- Who are sphingotec GmbH's investors?
- sphingotec GmbH's investors include Brandenburg Kapital, HBM Healthcare Investments, HBM Partners.
- Where is sphingotec GmbH headquartered?
- sphingotec GmbH is headquartered in Hennigsdorf, DE.

